ArticleScientific reports2017

Nucleotide based covalent inhibitors of KRas can only be efficient in vivo if they bind reversibly with GTP-like affinity.

Matthias P Müller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.